News Daily News Even After Recent ACS, Diabetic Patients With Multivessel Disease Fare Better With CABG L.A. McKeown December 11, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017